References
- Stefanovic V, Cosyns JP. Balkan nephropathy. In: Grunfeld JP, Ponticelli C, Van Ypersele C, Ritz E, Winearls CG, eds. Oxford Textbook of Clinical Nephrology. 3rd ed. Oxford: Oxford University Press; 2005:1095–1102
- Stefanovic V, Radovanovic Z. Balkan endemic nephropathy and associated urothelial cancer. Nat Clin Pract Urol. 2008;5:105–112
- Toncheva D, Dimitrov T, Stojanova S. Etiology of Balkan endemic nephropathy: A multifactorial disease. Eur J Epidemiol. 1998;14:389–394
- Stefanovic V, Toncheva D, Atanasova S, Polenakovic M. Etiology of Balkan endemic nephropathy and associated urothelial cancer. Am J Nephrol. 2006;26:1–11
- Ivic M. The problem of etiology of endemic nephropathy. Lijetc Vjes. 1969;91:1278–1281
- Petkova-Bocharova T, Chernozemsky IN, Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit Contam. 2002;19:282–302
- Stefanovic V, Cukuranovic R, Miljkovic S, Marinkovic D, Toncheva D. Fifty years of Balkan endemic nephropathy: Challenges of study using epidemiological method. Ren Fail. 2009;31:409–418
- Stefanovic V, Polenakovic MH. Balkan nephropathy. Kidney disease beyond the Balkans. Am J Nephrol. 1991;11:1–11
- De Broe ME. Chinese herbs nephropathy and Balkan endemic nephropathy: Toward a single entity, aristolochic acid nephropathy. Kidney Int. 2012;81:513–515
- Toncheva D, Mihailova-Hristova M, Vazharova R, et al. NGS nominated CELA1, HSPG2, and KCNK5 as candidate genes for predisposition to Balkan endemic nephropathy. Biomed Res Int. 2014; 2014:920723. doi: 10.1155/2014/920723
- Staneva R, Rukova B, Hadjidekova S, et al. Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology. BMC Nephrol. 2013;14:225
- Kocic G, Cukuranovic J, Stoimenov TJ, et al. Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease. Ren Fail. 2014;36:1078–1082
- Dewerchin M, Carmeliet P. PlGF: A multitasking cytokine with disease-restricted activity. Cold Spring Harb Perspect Med. 2012;2(8):pii: a011056
- Stefanović V, Jelaković B, Čukuranović R, et al. Diagnostic criteria for Balkan endemic nephropathy: Proposal by an international panel. Ren Fail. 2007;29:867–880
- Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28
- Luttun A, Tjwa M, Moons L, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831–840
- Bais C, Wu X, Yao J, et al. PlGF blockade does not inhibit angiogenesis during primary tumor growth. Cell. 2010;141:166–177
- Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure: Less of one, more of the other? Am J Hypert. 1988;1:335–347
- Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. New Engl J Med. 2003;348:101–108
- Luyckx VA, Bertram JF, Brenner BM, et al. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet. 2013;382:273–283